TNF ALFA blocking treatment in adult patients with juvenile idiopathic arthritis. Clinical efficacy and safety

被引：0
|
作者：
Jarosova, K
Svihalek, J
Dusek, L
Vencovsky, J
机构：
[1] Inst Rheumatol, Clin Dept, Prague, Czech Republic
[2] Ctr Biostat & Anal, Dept Stat, Brno, Czech Republic
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [22] Prognostic factors and outcome in patients with juvenile idiopathic arthritis.
    Cavalcanti, André
    Len, Claudio A.
    Terreri, Maria Teresa R. A.
    Barbosa, Cássia P.
    Hilário, Maria O. E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S686 - S686
  • [23] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [24] Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
    Alexeeva, Ekaterina I.
    Valieva, Saniya I.
    Bzarova, Tatyana M.
    Semikina, Elena L.
    Isaeva, Kseniya B.
    Lisitsyn, Alexander O.
    Denisova, Rina V.
    Chistyakova, Evgeniya G.
    CLINICAL RHEUMATOLOGY, 2011, 30 (09) : 1163 - 1172
  • [25] Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
    Ekaterina I. Alexeeva
    Saniya I. Valieva
    Tatyana M. Bzarova
    Elena L. Semikina
    Kseniya B. Isaeva
    Alexander O. Lisitsyn
    Rina V. Denisova
    Evgeniya G. Chistyakova
    Clinical Rheumatology, 2011, 30 : 1163 - 1172
  • [26] Efficacy and safety of treatment with Infliximab in patients with early Oligo- and Polyarticular Juvenile Idiopathic Arthritis
    Mitenko, Elena
    Alexeeva, Ekaterina
    Valieva, Sanya
    Bzarova, Tatyana
    Sleptsova, Tatyana
    Isaeva, Kseniya
    Lisitsyn, Alexander
    Denisova, Rina
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 439 - 439
  • [27] Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis
    Kearsley-Fleet, Lianne
    McErlane, Flora
    Foster, Helen E.
    Lunt, Mark
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RMD OPEN, 2016, 2 (02):
  • [28] DISCONTINUATION OF ANTI-TNF IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL REMISSION
    Camacho-Lovillo, M.
    Gil-Gonzaez, E.
    Pedraza, M. A. Gantes
    Lopez-Sabido, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 388 - 388
  • [29] Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
    Murdaca, Giuseppe
    Negrini, Simone
    Magnani, Ottavia
    Penza, Elena
    Pellecchio, Marco
    Gulli, Rossella
    Mandich, Paola
    Puppo, Francesco
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 417 - 431
  • [30] Safety of tocilizumab in the treatment of juvenile idiopathic arthritis
    Machado, Sandra Helena
    Xavier, Ricardo Machado
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 493 - 500
12345